Advanced

Apomorphininjektionstherapie bei Morbus Parkinson

Odin, Per LU ; Bilsing, A.; Durner, J. and Honig, H. (2011) In Aktuelle Neurologie 38(Suppl. 1). p.11-16
Abstract
Apomorphine as subcutaneous injections offers a valuable and effective treatment alternative for Parkinson patients with oral medication-resistant "off' phases. Its efficacy is stable during long-term therapy, with no signs of patient tolerance. Adverse events are usually mild. The best results are obtained with relatively young, active, and cognitively intact patients. Intermittent s.c. apomorphine therapy can improve the patients' possibilities to continue to work and to live a normal social life, by offering increased freedom and self-confidence through a reliable, quick rescue from the disabling medication-resistant off phases.
Please use this url to cite or link to this publication:
author
organization
alternative title
Apomorphine Injection Therapy for Parkinson's Disease
publishing date
type
Contribution to journal
publication status
published
subject
keywords
apomorphine, injection, subcutaneous, Parkinson, dopamine agonist
in
Aktuelle Neurologie
volume
38
issue
Suppl. 1
pages
11 - 16
publisher
Georg Thieme Verlag
external identifiers
  • wos:000289376300004
  • scopus:79951988435
ISSN
0302-4350
DOI
10.1055/s-0030-1265967
language
German
LU publication?
yes
id
44858212-84e7-4323-aee9-93989de99c02 (old id 1966172)
date added to LUP
2011-05-20 11:15:19
date last changed
2017-01-01 04:16:53
@article{44858212-84e7-4323-aee9-93989de99c02,
  abstract     = {Apomorphine as subcutaneous injections offers a valuable and effective treatment alternative for Parkinson patients with oral medication-resistant "off' phases. Its efficacy is stable during long-term therapy, with no signs of patient tolerance. Adverse events are usually mild. The best results are obtained with relatively young, active, and cognitively intact patients. Intermittent s.c. apomorphine therapy can improve the patients' possibilities to continue to work and to live a normal social life, by offering increased freedom and self-confidence through a reliable, quick rescue from the disabling medication-resistant off phases.},
  author       = {Odin, Per and Bilsing, A. and Durner, J. and Honig, H.},
  issn         = {0302-4350},
  keyword      = {apomorphine,injection,subcutaneous,Parkinson,dopamine agonist},
  language     = {ger},
  number       = {Suppl. 1},
  pages        = {11--16},
  publisher    = {Georg Thieme Verlag},
  series       = {Aktuelle Neurologie},
  title        = {Apomorphininjektionstherapie bei Morbus Parkinson},
  url          = {http://dx.doi.org/10.1055/s-0030-1265967},
  volume       = {38},
  year         = {2011},
}